Gert Eberlein

1.2k total citations
37 papers, 956 citations indexed

About

Gert Eberlein is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Gert Eberlein has authored 37 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 13 papers in Oncology. Recurrent topics in Gert Eberlein's work include Neuropeptides and Animal Physiology (15 papers), Peptidase Inhibition and Analysis (11 papers) and Protein purification and stability (5 papers). Gert Eberlein is often cited by papers focused on Neuropeptides and Animal Physiology (15 papers), Peptidase Inhibition and Analysis (11 papers) and Protein purification and stability (5 papers). Gert Eberlein collaborates with scholars based in United States, Germany and New Zealand. Gert Eberlein's co-authors include Thomas C. Bruice, H. Goebell, Viktor E. Eysselein, Joseph R. Reeve, Daniel Grandt, Pamela Stratton, Zahra Shahrokh, W. Niebel, John E. Shively and Paul R. Sleath and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Gert Eberlein

37 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gert Eberlein United States 19 431 392 147 140 139 37 956
Ronald C. Orlowski Canada 20 761 1.8× 649 1.7× 269 1.8× 49 0.3× 79 0.6× 49 1.2k
S. Bajusz Hungary 24 1.2k 2.7× 877 2.2× 226 1.5× 77 0.6× 92 0.7× 84 1.9k
Antao Dai China 22 1.2k 2.8× 613 1.6× 79 0.5× 135 1.0× 89 0.6× 45 1.8k
G. J. DURANT United Kingdom 16 804 1.9× 204 0.5× 80 0.5× 96 0.7× 59 0.4× 37 1.6k
David K. Apps United Kingdom 18 885 2.1× 187 0.5× 60 0.4× 103 0.7× 30 0.2× 41 1.2k
Kim O’Neill United States 16 384 0.9× 129 0.3× 51 0.3× 114 0.8× 417 3.0× 30 1.2k
D.K. Apps United Kingdom 17 738 1.7× 236 0.6× 68 0.5× 72 0.5× 23 0.2× 29 1.1k
Graeme F. Bryce United States 21 521 1.2× 62 0.2× 226 1.5× 77 0.6× 36 0.3× 39 1.4k
Tianya Liu China 15 611 1.4× 117 0.3× 75 0.5× 76 0.5× 112 0.8× 38 1.1k
Matilde Colella Italy 19 818 1.9× 194 0.5× 76 0.5× 79 0.6× 25 0.2× 38 1.3k

Countries citing papers authored by Gert Eberlein

Since Specialization
Citations

This map shows the geographic impact of Gert Eberlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gert Eberlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gert Eberlein more than expected).

Fields of papers citing papers by Gert Eberlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gert Eberlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gert Eberlein. The network helps show where Gert Eberlein may publish in the future.

Co-authorship network of co-authors of Gert Eberlein

This figure shows the co-authorship network connecting the top 25 collaborators of Gert Eberlein. A scholar is included among the top collaborators of Gert Eberlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gert Eberlein. Gert Eberlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Y. John, et al.. (2002). Characterization, Stability, and Formulations of Basic Fibroblast Growth Factor. Pharmaceutical biotechnology. 9. 141–180. 25 indexed citations
2.
Chang, Paul, et al.. (2000). Characterization of bovine collagens using capillary electrophoresis — an alternative to slab gel electrophoresis. Journal of Pharmaceutical and Biomedical Analysis. 22(6). 957–966. 14 indexed citations
3.
Eberlein, Gert, et al.. (1999). Use of acarbose for eliminating the interval between meal consumption and insulin injection in patients with Type 1 diabetes.. PubMed. 12(3). 195–201. 3 indexed citations
4.
5.
Eberlein, Gert. (1995). Quantitation of proteins using HPLC-detector response rather than standard curve comparison. Journal of Pharmaceutical and Biomedical Analysis. 13(10). 1263–1271. 13 indexed citations
6.
Shahrokh, Zahra, et al.. (1994). Approaches to Analysis of Aggregates and Demonstrating Mass Balance in Pharmaceutical Protein (Basic Fibroblast Growth Factor) Formulations†. Journal of Pharmaceutical Sciences. 83(12). 1645–1650. 17 indexed citations
7.
Sluzky, Victoria, et al.. (1994). Chromatographic Methods for Quantitative Analysis of Native, Denatured, and Aggregated Basic Fibroblast Growth Factor in Solution Formulations. Pharmaceutical Research. 11(4). 485–490. 20 indexed citations
8.
Shahrokh, Zahra, et al.. (1994). Probing the conformation of protein (bFGF) precipitates by fluorescence spectroscopy. Journal of Pharmaceutical and Biomedical Analysis. 12(8). 1035–1041. 7 indexed citations
9.
Eberlein, Gert, et al.. (1993). Comparison of clearance and metabolism of infused cholecystokinins 8 and 58 in dogs. Gastroenterology. 105(6). 1732–1736. 39 indexed citations
10.
Zwiauer, Karl, Gert Eberlein, & Kurt Widhalm. (1991). Inverse relationship between diastolic blood pressure and urinary excretion of potassium in girls aged 8 to 9 years--a preliminary communication.. PubMed. 103(17). 519–23. 4 indexed citations
11.
Springer, Caroline J., et al.. (1991). Accelerated in vitro degradation of CCK-58 in blood and plasma of patients with acute pancreatitis. Clinica Chimica Acta. 198(3). 245–253. 8 indexed citations
12.
Reeve, Joseph R., Viktor E. Eysselein, Gert Eberlein, et al.. (1991). Characterization of canine intestinal cholecystokinin-58 lacking its carboxyl-terminal nonapeptide. Evidence for similar post-translational processing in brain and gut. Journal of Biological Chemistry. 266(21). 13770–13776. 15 indexed citations
13.
Mössner, Joachim, Jörg M. Zeeh, Gert Eberlein, et al.. (1991). Determination of Various Molecular Forms of Cholecystokinin from Canine Mucosa by Radioimmunoassay and Bioassay. Digestion. 48(4). 210–219. 6 indexed citations
14.
Eysselein, Viktor E., Gert Eberlein, Daniel Grandt, et al.. (1990). Structural characterization of canine PYY. Peptides. 11(1). 111–116. 26 indexed citations
15.
Eysselein, Viktor E., et al.. (1990). Action of Neurotensin on Meal-Stimulated Gastric Acid Secretion in the Dog. Scandinavian Journal of Gastroenterology. 25(1). 29–39. 5 indexed citations
16.
Mössner, Joachim, et al.. (1989). Influence of food on plasma cholecystokinin and gastrin in patients with partial gastric resections and Roux-en-Y anastomosis.. PubMed. 27(2). 94–8. 6 indexed citations
17.
Eberlein, Gert, Viktor E. Eysselein, Peter Layer, et al.. (1989). A new molecular form of PYY: Structural characterization of human PYY(3–36) and PYY(1–36). Peptides. 10(4). 797–803. 110 indexed citations
18.
Eberlein, Gert, Viktor E. Eysselein, & H. Goebell. (1988). Cholecystokinin-58 is the major molecular form in man, dog and cat but not in pig, beef and rat intestine. Peptides. 9(5). 993–998. 32 indexed citations
19.
20.
Eberlein, Gert & Thomas C. Bruice. (1982). One and two electron reduction of oxygen by 1,5-dihydroflavins. Journal of the American Chemical Society. 104(5). 1449–1452. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald C. Orlowski Breakdown of academic impact, for papers by S. Bajusz Breakdown of academic impact, for papers by Antao Dai Breakdown of academic impact, for papers by G. J. DURANT Breakdown of academic impact, for papers by David K. Apps Breakdown of academic impact, for papers by Kim O’Neill Breakdown of academic impact, for papers by D.K. Apps Breakdown of academic impact, for papers by Graeme F. Bryce Breakdown of academic impact, for papers by Tianya Liu Breakdown of academic impact, for papers by Matilde Colella
Rankless by CCL
2026